Search Results - "Thiemann, Meinolf"

Refine Results
  1. 1
  2. 2
  3. 3

    Translational PBPK Modeling of the Protein Therapeutic and CD95L Inhibitor Asunercept to Develop Dose Recommendations for Its First Use in Pediatric Glioblastoma Patients by Hanke, Nina, Kunz, Claudia, Thiemann, Meinolf, Fricke, Harald, Lehr, Thorsten

    Published in Pharmaceutics (01-04-2019)
    “…The protein therapeutic and CD95L inhibitor asunercept is currently under clinical investigation for the treatment of glioblastoma and myelodysplastic…”
    Get full text
    Journal Article
  4. 4

    3D Cellular Architecture Modulates Tyrosine Kinase Activity, Thereby Switching CD95-Mediated Apoptosis to Survival by Gülcüler Balta, Gülce S., Monzel, Cornelia, Kleber, Susanne, Beaudouin, Joel, Balta, Emre, Kaindl, Thomas, Chen, Si, Gao, Liang, Thiemann, Meinolf, Wirtz, Christian R., Samstag, Yvonne, Tanaka, Motomu, Martin-Villalba, Ana

    Published in Cell reports (Cambridge) (19-11-2019)
    “…The death receptor CD95 is expressed in every cancer cell, thus providing a promising tool to target cancer. Activation of CD95 can, however, lead to apoptosis…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8

    A Single-Chain-Based Hexavalent CD27 Agonist Enhances T Cell Activation and Induces Anti-Tumor Immunity by Thiemann, Meinolf, Richards, David M, Heinonen, Karl, Kluge, Michael, Marschall, Viola, Merz, Christian, Redondo Müller, Mauricio, Schnyder, Tim, Sefrin, Julian P, Sykora, Jaromir, Fricke, Harald, Gieffers, Christian, Hill, Oliver

    Published in Frontiers in oncology (19-09-2018)
    “…Tumor necrosis factor receptor superfamily member 7 (TNFRSF7, CD27), expressed primarily by T cells, and its ligand CD27L (TNFSF7, CD70) provide co-stimulatory…”
    Get full text
    Journal Article
  9. 9

    Dynamin-like Protein 1 Is Involved in Peroxisomal Fission by Koch, Annett, Thiemann, Meinolf, Grabenbauer, Markus, Yoon, Yisang, McNiven, Mark A, Schrader, Michael

    Published in The Journal of biological chemistry (07-03-2003)
    “…The mammalian dynamin-like protein 1 (DLP1), a member of the dynamin family of large GTPases, possesses mechanochemical properties known to constrict and…”
    Get full text
    Journal Article
  10. 10

    Abstract 4529: Neutralization of pro-apoptotic CD95L by Asunercept/APG101 does not impair anti-tumor immune responses by Merz, Christian, Sykora, Jaromir, Hussong, Rebecca, Thiemann, Meinolf, Hill, Oliver, Gieffers, Christian

    Published in Cancer research (Chicago, Ill.) (15-08-2020)
    “…Abstract The CD95 ligand (CD95L) is frequently overexpressed in cancers and tumor-associated endothelia, but also other immune cells like MDSCs and Tregs…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Abstract 4460: Novel bispecific molecules combining HERA-CD40L with anti-CEA or with anti-PD-L1 for targeting by Thiemann, Meinolf, Billian-Frey, Katharina, Schröder, Matthias, Merz, Christian, Sykora, Jaromir, Richards, David M., Müller, Mauricio Redondo, Sefrin, Julian P., Heinonen, Karl, Gieffers, Christian, Hill, Oliver

    Published in Cancer research (Chicago, Ill.) (15-08-2020)
    “…Abstract CD40 ligand is a member of the TNF superfamily and a key regulator of the immune system. Its cognate receptor CD40 is expressed on antigen-presenting…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Abstract 1760: The hexavalent CD40 agonist HERA-CD40L augments multi-level crosstalk between T cells and antigen-presenting cells by Merz, Christian, Sykora, Jaromir, Marschall, Viola, Richards, David M., Thiemann, Meinolf, Fricke, Harald, Hill, Oliver, Gieffers, Christian

    Published in Cancer research (Chicago, Ill.) (01-07-2018)
    “…Abstract Introduction: HERA-CD40L is a novel hexavalent CD40 agonist engineered with the HERA-Technology developed by Apogenix. We have previously shown that…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Infiltration of circulating myeloid cells through CD95L contributes to neurodegeneration in mice by Gao, Liang, Brenner, David, Llorens-Bobadilla, Enric, Saiz-Castro, Gonzalo, Frank, Tobias, Wieghofer, Peter, Hill, Oliver, Thiemann, Meinolf, Karray, Saoussen, Prinz, Marco, Weishaupt, Jochen H, Martin-Villalba, Ana

    Published in The Journal of experimental medicine (06-04-2015)
    “…Neuroinflammation is increasingly recognized as a hallmark of neurodegeneration. Activated central nervous system-resident microglia and infiltrating immune…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Abstract 464: Methylation of a single CpG site in the CD95-ligand promoter is a biomarker predicting the response to therapy with APG101 in glioblastoma by Gieffers, Christian, Kunz, Claudia, Sykora, Jaromir, Merz, Christian, Thiemann, Meinolf, Fricke, Harald, Wiestler, Benedikt, Wick, Wolfgang

    Published in Cancer research (Chicago, Ill.) (15-07-2016)
    “…Abstract CD95 (APO-1/Fas) is a member of the Tumor Necrosis Factor Receptor Super Family. Binding of CD95-ligand (CD95L) to CD95 triggers intracellular signal…”
    Get full text
    Journal Article
  20. 20

    Abstract 1688: HERA-CD40L: A novel hexavalent CD40 agonist with superior biological activity by Merz, Christian, Sykora, Jaromir, Thiemann, Meinolf, Marschall, Viola, Heinonen, Karl H., Fricke, Harald, Gieffers, Christian, Hill, Oliver

    Published in Cancer research (Chicago, Ill.) (01-07-2017)
    “…Abstract Introduction: Targeted therapeutics for cancer treatment are mostly developed as antibodies, however, the natural signaling complexes of the members…”
    Get full text
    Journal Article